Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

The ongoing evolution of Medical Affairs

April 14, 2023 | #COVID19, AI, Eddie Power, Healthcare Technology, Impetus Digital, Medical Affairs Pharma, Medical Affairs Teams, Natalie Yeadon, Pfizer, bioethics, blockchain, data privacy, machine learning, medical affairs, pharma technology, silico trials 

In the latest episode of Impetus Digital’s Fireside Chat series, Natalie Yeadon, Co-Founder and CEO of Impetus Digital talks to Eddie Power, Vice President of North America Medical Affairs, Hospital Business at Pfizer.They discuss a range of topics, including the effects of COVID-19 on the way Medical Affairs teams work and interact with the healthcare community. They also delve into the concept of ‘systems thinking’ and how this line of thinking can be applied within Medical Affairs and Pharma as a whole. Further, Eddie gives his thoughts on the role of technology in applying systems thinking, including barriers such as concerns about data privacy and bioethics. Other topics explored include innovative concepts such as in silico trials, AI and machine learning, and blockchain.

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

Let everyone have a say; the top 10 benefits of virtual advisory boards

Here’s another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #7. Everyone Gets a Say Another top benefit for the…

Capture Tribal Knowledge, Top 10 benefits of virtual advisory boards

We’re breaking down the benefits of virtual advisory boards, and how they are superior when compared to in-person and hybrid advisory boards. #6. Far Superior Convenience Most KOLs have extremely…

Capture Tribal Knowledge in Advisory Boards

We’re breaking down the benefits of virtual advisory boards, and how they are superior when compared to in-person and hybrid advisory boards. #5. The Ability to Capture “Tribal Knowledge” and…

Create Long-lasting KOL Relationships, benefits of virtual advisory boards

Here’s another top reason why virtual advisory boards are simply better than in-person and hybrid advisory boards. #4. More Frequent Interactions and Long-lasting KOL Relationships Another important benefit of online…

Increased Timeliness for yor Advisory Boards

We’ve broken down the top ten benefits of why virtual advisory boards are superior to in-person and hybrid advisory boards. #3. Increased Timeliness to Insight-gathering and Output Delivery Based on…

Ten ways to start (or continue) your patient engagement journey

Here are 10 easy approaches Pharma teams can take when starting (or continuing) their patient engagement journey!

Increased Timeliness to Insight-gathering and Output Delivery in Virtual Advisory Boards

We’ve broken down the top ten benefits of why virtual advisory boards are superior to in-person and hybrid advisory boards. #3. Increased Timeliness to Insight-gathering and Output Delivery Based on…

Top 10 benefits of virtual advisory boards: Increased Engagement and Insights

#2. Increased Advisor Engagement and Quality and Quantity of Insights

Top 10 benefits of virtual advisory boards: Save Time and Resources

We’ve broken down the top ten benefits of why virtual advisory boards are superior to in-person and hybrid advisory boards. #1. Countless Hours of Time-savings and Substantially Reduced Costs We’ll…

10 Important Advisor Questions: Placement of Your Product in the Current/Future Treatment Algorithm

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here’s another one to keep in…